Covered recipient · General Payments record
LILA CHERRY
Allopathic & Osteopathic Physicians Physical Medicine & Rehabilitation
General Payments · PY2018–2024
$3,084.71
- Reported across 186 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $294.77 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $207.03 | 14 |
| JAZZ PHARMACEUTICALS INC. | $69.83 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.85 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456742 | CMS |
| ABBVIE INC. | $20.08 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456744 | CMS |
| ABBVIE INC. | $19.98 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456746 | CMS |
| ABBVIE INC. | $15.29 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456748 | CMS |
| ABBVIE INC. | $4.33 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456750 | CMS |
| ABBVIE INC. | $14.15 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456752 | CMS |
| ABBVIE INC. | $2.67 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456754 | CMS |
| ABBVIE INC. | $18.70 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456756 | CMS |
| ABBVIE INC. | $15.89 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456758 | CMS |
| ABBVIE INC. | $20.50 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456760 | CMS |
| ABBVIE INC. | $6.25 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456762 | CMS |
| ABBVIE INC. | $15.15 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456764 | CMS |
| ABBVIE INC. | $19.96 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456766 | CMS |
| ABBVIE INC. | $16.23 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103456768 | CMS |
| JAZZ PHARMACEUTICALS INC. | $21.73 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150238204 | CMS |
| JAZZ PHARMACEUTICALS INC. | $22.21 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150238206 | CMS |
| JAZZ PHARMACEUTICALS INC. | $25.89 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150238208 | CMS |
| Novartis Pharmaceuticals Corporation | $17.91 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086742097 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.